Rankings
▼
Calendar
QTTB Q4 2024 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena
QTTB
Q32 Bio Inc.
$73M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
+100.0% YoY
Gross Profit
$0
Operating Income
-$15M
Net Income
-$14M
EPS (Diluted)
$-1.16
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$92M
Total Liabilities
$87M
Stockholders' Equity
$6M
Cash & Equivalents
$78M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
-$15M
+100.0%
Gross Profit
$0
-$15M
+100.0%
Operating Income
-$15M
-$26M
+43.7%
Net Income
-$14M
-$27M
+47.6%
← FY 2024
All Quarters
Q1 2025 →